ID   G3.32.2
AC   CVCL_1Q46
DR   cancercelllines; CVCL_1Q46
DR   Wikidata; Q54835392
RX   PubMed=6686281;
RX   PubMed=6951167;
CC   Problematic cell line: Contaminated. Parent cell line (F-137) has been shown to be a Jiyoye derivative.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q45 ! F-137
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 14
RX   PubMed=6686281; DOI=10.1128/mcb.3.12.2259-2270.1983;
RA   Benham F.J., Wiles M.V., Goodfellow P.N.;
RT   "Differentiation in vitro of human-mouse teratocarcinoma hybrids.";
RL   Mol. Cell. Biol. 3:2259-2270(1983).
RX   PubMed=6951167; DOI=10.1073/pnas.79.4.1190;
RA   Goodfellow P.N., Banting G.S., Trowsdale J., Chambers S., Solomon E.;
RT   "Introduction of a human X-6 translocation chromosome into a mouse
RT   teratocarcinoma: investigation of control of HLA-A, B, C expression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:1190-1194(1982).